Invests in
Sectors:
Locations:
Min Investment:
$50,000.00Max Investment:
$150,000.00Target Investment:
$100,000.00
Skills
Education
- Uo
- SM
Lists including Jessica
Work Experience
Vice President
2025
๐ ๐๐๐ฟ๐ฎ๐๐ฒ๐ด๐ถ๐ฐ ๐ฐ๐ผ๐ป๐๐๐น๐๐ถ๐ป๐ด ๐ณ๐ถ๐ฟ๐บ ๐๐ต๐ฎ๐ ๐ต๐ฒ๐น๐ฝ๐ ๐ผ๐ฟ๐ด๐ฎ๐ป๐ถ๐๐ฎ๐๐ถ๐ผ๐ป๐ ๐๐ฒ๐ฐ๐๐ฟ๐ฒ ๐ณ๐๐ป๐ฑ๐ถ๐ป๐ด. Advise research-driven for-profit and nonprofit clientsโincluding healthtech startups and research institutionsโon securing competitive federal and private funding. Focus on funding strategy, positioning, proposal development, and evaluation to help teams compete and scale. Draw on a background in biomedical research and venture capital to support clients in healthtech and adjacent sectors. www.tigdc.com
2024
Venture Capital Cohort Member (Class '24)
2024
๐ โ๐๐ป๐ถ๐พ๐๐ฒ ๐ณ๐ฎ๐๐-๐๐ฟ๐ฎ๐ฐ๐ธ ๐ ๐๐ ๐ณ๐ผ๐ฟ ๐๐ฒ๐ป๐๐๐ฟ๐ฒ ๐ฐ๐ฎ๐ฝ๐ถ๐๐ฎ๐นโ ๐ณ๐ผ๐ฟ ๐ฒ๐ ๐๐ฟ๐ฎ๐ผ๐ฟ๐ฑ๐ถ๐ป๐ฎ๐ฟ๐ ๐น๐ฒ๐ฎ๐ฑ๐ฒ๐ฟ๐. ๐๐ป๐ฐ๐น๐๐ฑ๐ฒ๐ฑ ๐ฉ๐ ๐ถ๐ ๐๐ต๐ฒ ๐ณ๐ถ๐ฟ๐๐ & ๐ผ๐ป๐น๐ ๐ผ๐ณ ๐ถ๐๐ ๐ธ๐ถ๐ป๐ฑ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐ณ๐๐น๐น๐ ๐ณ๐๐ป๐ฑ๐ฒ๐ฑ ๐๐ฒ๐น๐น๐ผ๐๐๐ต๐ถ๐ฝ ๐ณ๐ผ๐ฟ ๐ถ๐ป๐ฑ๐ถ๐๐ถ๐ฑ๐๐ฎ๐น๐ ๐ณ๐ฟ๐ผ๐บ ๐ผ๐๐ฒ๐ฟ๐น๐ผ๐ผ๐ธ๐ฒ๐ฑ & ๐ฑ๐ถ๐๐ฒ๐ฟ๐๐ฒ ๐ฐ๐ผ๐บ๐บ๐๐ป๐ถ๐๐ถ๐ฒ๐. Over 75% of those Fellows that were actively looking for a role have broken into the venture capital ecosystem globally โ from Asia to Europe to Africa to the Americas. Included VC is supported by an international consortium of venture capital partners and sponsors including: BITKRAFT, Creandum, Daphni, European Investment Fund, Esprit Foundation, HSBC Ventures, HV Capital, Mouro Capital, Mangrove Capital, Notion Capital, Seedcamp and Wilson Sonsini. Included VC has been featured by the likes of Forbes, Sky News, CNBC & Business Insider.
2024
Venture Partner, Health Tech
2024
๐๐ป ๐ฎ๐ป๐ด๐ฒ๐น ๐๐๐ป๐ฑ๐ถ๐ฐ๐ฎ๐๐ฒ ๐ฎ๐ป๐ฑ ๐๐ฒ๐ป๐๐๐ฟ๐ฒ ๐ฐ๐ฎ๐ฝ๐ถ๐๐ฎ๐น ๐๐ฟ๐ฎ๐ถ๐ป๐ถ๐ป๐ด ๐ฝ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ ๐๐ต๐ฒ๐ฟ๐ฒ ๐ ๐๐ผ๐๐ฟ๐ฐ๐ฒ๐ฑ ๐ฎ๐ป๐ฑ ๐ฒ๐๐ฎ๐น๐๐ฎ๐๐ฒ๐ฑ ๐ต๐ฒ๐ฎ๐น๐๐ต ๐๐ฒ๐ฐ๐ต ๐๐๐ฎ๐ฟ๐๐๐ฝ๐, ๐๐๐ฝ๐ฝ๐ผ๐ฟ๐๐ฒ๐ฑ ๐ณ๐ผ๐๐ป๐ฑ๐ฒ๐ฟ๐ ๐๐ถ๐๐ต ๐ณ๐๐ป๐ฑ๐ฟ๐ฎ๐ถ๐๐ถ๐ป๐ด ๐๐๐ฟ๐ฎ๐๐ฒ๐ด๐ถ๐ฒ๐ Source, diligence, and pitch investment opportunities in health tech. Advise founders on growth strategies and connect them with resources.
2024 - 2025
Founder
2024 - 2025
BioMed VC Insights (BVCI) was born out of a simple observation: founders building breakthrough biomedical solutions often struggle with one of the most critical partsโfunding. BVCI helps founders bridge the gap between non-dilutive and venture capital financing. Through Funding for Founders (https://www.bvci.io/), I provide plainspoken strategies, resources, and tools to demystify grant fundingโespecially NIH and SBIR/STTR. My work combines deep grant expertise with a venture-informed perspective, helping founders make smarter decisions across their entire funding journey.
2020 - 2025
Executive Director, Longevity, Equity, and Aging Research Consortium (formerly SAGE)
2020 - 2025
๐๐ป ๐ฎ๐ฐ๐ฎ๐ฑ๐ฒ๐บ๐ถ๐ฐ ๐ฐ๐ผ๐ป๐๐ผ๐ฟ๐๐ถ๐๐บ ๐ณ๐ผ๐ฐ๐๐๐ฒ๐ฑ ๐ผ๐ป ๐ฎ๐ฑ๐๐ฎ๐ป๐ฐ๐ถ๐ป๐ด ๐ฎ๐ด๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐น๐ผ๐ป๐ด๐ฒ๐๐ถ๐๐ ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐๐ผ ๐ถ๐บ๐ฝ๐ฟ๐ผ๐๐ฒ ๐๐ต๐ฒ ๐พ๐๐ฎ๐น๐ถ๐๐ ๐ผ๐ณ ๐น๐ถ๐ณ๐ฒ ๐ผ๐ณ ๐ผ๐น๐ฑ๐ฒ๐ฟ ๐ฎ๐ฑ๐๐น๐๐, ๐๐ต๐ฒ๐ฟ๐ฒ ๐ ๐น๐ฒ๐ฑ ๐ถ๐ป๐ถ๐๐ถ๐ฎ๐๐ถ๐๐ฒ๐ ๐๐ผ ๐ถ๐ป๐ฐ๐ฟ๐ฒ๐ฎ๐๐ฒ ๐ฑ๐ถ๐๐ฒ๐ฟ๐๐ถ๐๐ ๐ถ๐ป ๐ฏ๐ถ๐ผ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ฎ๐ป๐ฑ ๐ฏ๐๐ถ๐น๐ ๐๐ฐ๐ฎ๐น๐ฎ๐ฏ๐น๐ฒ ๐ฝ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ ๐ถ๐ป๐ณ๐ฟ๐ฎ๐๐๐ฟ๐๐ฐ๐๐๐ฟ๐ฒ. Manage the seed grant program with 22 projects on developing patient-centric solutions in digital health technologies, disease diagnostics, and tools for drug development. Acquired $4M in grant funding for biomedical and clinical research projects. Transformed the SAGE Research Center into the Longevity, Equity, and Aging Research Consortium by building key partnerships with 3 academic institutions, 2 healthcare networks in California, and various community organizations. Manage compliance for 25 biomedical and clinical trials, ensuring adherence to institutional and federal regulations.
2018 - 2020
Research Development Associate, Biomedical Sciences, Research Development Services
2018 - 2020
๐๐ป ๐ฅ๐ญ ๐ฎ๐ฐ๐ฎ๐ฑ๐ฒ๐บ๐ถ๐ฐ ๐ฟ๐ฒ๐๐ฒ๐ฎ๐ฟ๐ฐ๐ต ๐ถ๐ป๐๐๐ถ๐๐๐๐ถ๐ผ๐ป ๐๐ต๐ฒ๐ฟ๐ฒ ๐ ๐๐ฒ๐ฐ๐๐ฟ๐ฒ๐ฑ $๐ฏ๐ญ๐ ๐ถ๐ป ๐ฏ๐ถ๐ผ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐ณ๐๐ป๐ฑ๐ถ๐ป๐ด ๐ฎ๐ป๐ฑ ๐ฑ๐ฒ๐๐ถ๐ด๐ป๐ฒ๐ฑ ๐ด๐ฟ๐ฎ๐ป๐ ๐ฝ๐ฟ๐ผ๐ด๐ฟ๐ฎ๐บ๐ ๐๐ผ ๐๐๐ฝ๐ฝ๐ผ๐ฟ๐ ๐ฒ๐ฑ๐๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐ฎ๐น ๐ฎ๐ฐ๐ฐ๐ฒ๐๐ ๐ณ๐ผ๐ฟ ๐๐ป๐ฑ๐ฒ๐ฟ๐๐ฒ๐ฟ๐๐ฒ๐ฑ ๐ฐ๐ผ๐บ๐บ๐๐ป๐ถ๐๐ถ๐ฒ๐. Consulted with biomedical researchers in the 5 health science colleges on project design, resulting in acquisition of $31M in research grant funding in 2 years. Presented 41 seminars and workshops on biomedical project design, human subjects research compliance, identifying funding opportunities, effective pitching/communication, and building partnerships.
2017 - 2019
Specialist Editor, Biochemistry, Genetics, and Molecular Biology
2017 - 2019
๐ ๐ด๐น๐ผ๐ฏ๐ฎ๐น ๐๐ฐ๐ถ๐ฒ๐ป๐๐ถ๐ณ๐ถ๐ฐ ๐ฐ๐ผ๐บ๐บ๐๐ป๐ถ๐ฐ๐ฎ๐๐ถ๐ผ๐ป๐ ๐ฐ๐ผ๐บ๐ฝ๐ฎ๐ป๐ ๐๐ต๐ฒ๐ฟ๐ฒ ๐ ๐ฒ๐ฑ๐ถ๐๐ฒ๐ฑ ๐ฎ๐ป๐ฑ ๐ฐ๐ผ๐ป๐๐๐น๐๐ฒ๐ฑ ๐ผ๐ป ๐ฏ๐ถ๐ผ๐บ๐ฒ๐ฑ๐ถ๐ฐ๐ฎ๐น ๐๐ฟ๐ถ๐๐ถ๐ป๐ด ๐ฝ๐ฟ๐ผ๐ท๐ฒ๐ฐ๐๐ ๐ณ๐ผ๐ฟ ๐ฝ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ฒ๐๐๐ถ๐ฐ๐ฎ๐น ๐ฎ๐ป๐ฑ ๐ฎ๐ฐ๐ฎ๐ฑ๐ฒ๐บ๐ถ๐ฐ ๐ฐ๐น๐ถ๐ฒ๐ป๐๐. Consulted on and edited 140 biomedical writing projects across therapeutic areas for drug companies and academic investigators, including primary research articles, review articles, and an Investigational New Drug (IND) application.
2017 - 2017
Biomedical Research and Funding Consultant
2017 - 2017
Consulted on research portfolio development, biomedical project design, and funding acquisition, resulting in acquisition of a prestigious grant and publication of 5 peer-reviewed manuscripts.